Bioxtract Overview
- Year Founded
-
2003
- Status
-
Private
- Employees
-
3
- Latest Deal Type
-
2ndary - Private
- Investors
-
1
Bioxtract General Information
Description
Developer and manufacturer of innovative food supplements or ingredients intended to offer ready-to-use finished dosages of supplements for pharmaceutical and food supplement industries and export markets. The company's food supplements are made from natural active ingredients, based on bibliographical pre-clinical and clinical evidence, enabling medical professionals to treat a particular target using a specific formulation.
Contact Information
Website
www.bioxtract.comCorporate Office
- Parc Scientifique Créalys
- Rue Guillaume Fouquet 30
- 5032 Isnes
- Belgium
Corporate Office
- Parc Scientifique Créalys
- Rue Guillaume Fouquet 30
- 5032 Isnes
- Belgium
Bioxtract Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Secondary Transaction - Private | 01-Feb-2021 | Completed | Generating Revenue | |||
| 2. Early Stage VC | 17-Feb-2004 | Completed | Generating Revenue | |||
| 1. University Spin-Out | 01-Jan-2003 | Completed |
Bioxtract Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Category B | ||||||||
| Category B | ||||||||
| Category A | 4,130 | $31.56 | $31.56 | 1x | $31.56 | 42.36% |
Bioxtract Patents
Bioxtract Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-2229940-A1 | Pharmaceutical composition presenting anti-inflammatory and anti-histaminic properties | Active | 20-Mar-2009 | ||
| EP-2229940-B1 | Pharmaceutical composition presenting anti-inflammatory and anti-histaminic properties | Inactive | 20-Mar-2009 | ||
| AU-2010224811-A1 | Pharmaceutical composition presenting anti-inflammatory properties | Active | 20-Mar-2009 | ||
| AU-2010224811-B2 | Pharmaceutical composition presenting anti-inflammatory properties | Inactive | 20-Mar-2009 | ||
| EP-2408442-A1 | Pharmaceutical composition presenting anti-inflammatory properties | Active | 20-Mar-2009 | A61K9/4858 |
Bioxtract Signals
Bioxtract Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| University of Liege | University |
Bioxtract FAQs
-
When was Bioxtract founded?
Bioxtract was founded in 2003.
-
Where is Bioxtract headquartered?
Bioxtract is headquartered in Isnes, Belgium.
-
What is the size of Bioxtract?
Bioxtract has 3 total employees.
-
What industry is Bioxtract in?
Bioxtract’s primary industry is Biotechnology.
-
Is Bioxtract a private or public company?
Bioxtract is a Private company.
-
What is Bioxtract’s current revenue?
The current revenue for Bioxtract is .
-
How much funding has Bioxtract raised over time?
Bioxtract has raised $694K.
-
Who are Bioxtract’s investors?
University of Liege has invested in Bioxtract.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process